The DOI matches its Crossref record.
Intravenous TAT–Bcl‐Xl is protective after middle cerebral artery occlusion in mice
Abstract
The delivery of proteins across the blood–brain barrier is severely limited by the proteins' size and biochemical properties. Eleven–amino acid human immunodeficiency virus TAT protein is able to cross cell membranes even when coupled with larger peptides. We evaluated whether TAT–Bcl‐X L fusion protein is protective in focal ischemia. Mice underwent 30 or 90 minutes of intraluminal middle cerebral artery thread occlusion. TAT–Bcl‐X L, TAT–β‐galactosidase, or TAT‐GFP (0.6nmol each) were applied intravenously over 10 minutes either 1 hour before or immediately after ischemia. Additional animals received no TAT protein infusions. We show that the brain tissue is progressively transduced with TAT proteins within 3 to 4 hours after intravenous delivery. We provide evidence that TAT–Bcl‐X L treatment reduces infarct volume and neurological deficits after long ischemic insults lasting 90 minutes, when applied both before and after ischemia. After short insults, lasting only 30 minutes, TAT–Bcl‐X L further diminishes the number of caspase‐3–reactive and DNA fragmented cells and increases the number of viable neurons in the striatum. Our results indicate that TAT fusion proteins are elegant and powerful tools that might be of clinical interest for stroke treatment, because factors may be intravenously applied. Thus, fusion proteins may open fascinating perspectives for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Apoptotic Mechanisms After Cerebral Ischemia
Broughton, B. R. S., Reutens, D. C., & Sobey, C. G. (2009) · Stroke · doi:10.1161/strokeaha.108.531632 · Cited by 1,266
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Apoptosis and caspases regulate death and inflammation in sepsis
Hotchkiss, R. S., & Nicholson, D. W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1943 · Cited by 795
CNS Delivery Via Adsorptive Transcytosis
Hervé, F., Ghinea, N., & Scherrmann, J.-M. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9055-2 · Cited by 676
Delivery of bioactive molecules into the cell: the Trojan horse approach
Dietz, G. P. H., & Bähr, M. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.03.005 · Cited by 469
Self-citationBlood–brain barrier shuttle peptides: an emerging paradigm for brain delivery
Oller-Salvia, B., Sánchez-Navarro, M., Giralt, E., & Teixidó, M. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00076b · Cited by 442
Mitochondrial membrane permeabilization in neuronal injury
Galluzzi, L., Blomgren, K., & Kroemer, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2665 · Cited by 418
Characterisation of cell‐penetrating peptide‐mediated peptide delivery
Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M. V., Newham, P., & Lindsay, M. A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706279 · Cited by 385
Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 343
Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury
Starkov, A. A., Chinopoulos, C., & Fiskum, G. (2004) · Cell Calcium · doi:10.1016/j.ceca.2004.02.012 · Cited by 339
Mitochondrial mechanisms of neural cell apoptosis
Polster, B. M., & Fiskum, G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02572.x · Cited by 327
Pathophysiology of Stroke: Lessons from Animal Models
Mergenthaler, P., Dirnagl, U., & Meisel, A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000043966.46964.e6 · Cited by 325
Cell Penetrating Peptides in Drug Delivery
Snyder, E. L., & Dowdy, S. F. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000019289.61978.f5 · Cited by 323
Molecular Mechanisms of Apoptosis in Cerebral Ischemia: Multiple Neuroprotective Opportunities
Nakka, V. P., Gusain, A., Mehta, S. L., & Raghubir, R. (2008) · Molecular Neurobiology · doi:10.1007/s12035-007-8013-9 · Cited by 261
Kilic, E., Kilic, Ü., Wang, Y., Bassetti, C. L., Marti, H. H., Hermann, D. M., Kilic, E., Kilic, Ü., Wang, Y., Bassetti, C. L., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4829fje · Cited by 218
Self-citationAziz, M., Jacob, A., & Wang, P. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.488 · Cited by 125
“Recent studies have shown that large macromolecular cargos, proteins and peptides can be delivered intracellularly if conjugated to permeation peptides that are derived from transcriptional transactivator (Tat)-basic domains.(76,77) Hotchkiss et al.”
BackgroundNeural stem/precursor cells for the treatment of ischemic stroke
Bacigaluppi, M., Pluchino, S., Martino, G., Kilic, E., & Hermann, D. M. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.012 · Cited by 111
Self-citationKilic, Ü., Bassetti, C. L., Kilic, E., Xing, H., Wang, Z., & Hermann, D. M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.063 · Cited by 43
Self-citation
Metadata
- Authors
- Kilic, E., Dietz, G. P. H., Hermann, D. M., & Bähr, M.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2002-09-25
- Volume
- 52
- Issue
- 5
- Pages
- 617-622
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2059779950
- Cited by
- 166
- References
- 0
- FWCI
- 9.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.